A Phase 1/2 Study of the Oral Janus Kinase 1 Inhibitors INCB052793 and Itacitinib Alone or in Combination With Standard Therapies for Advanced Hematologic Malignancies
Titel:
A Phase 1/2 Study of the Oral Janus Kinase 1 Inhibitors INCB052793 and Itacitinib Alone or in Combination With Standard Therapies for Advanced Hematologic Malignancies
Auteur:
Zeidan, Amer M. Cook, Rachel J. Bordoni, Rodolfo Berenson, James R. Edenfield, William J. Mohan, Sanjay Zhou, Gongfu Asatiani, Ekaterine Srinivas, Nithya Savona, Michael R.